RxDoctor Payments Data

Brian Mannino, MD

Orthopaedic Surgery · Honolulu, HINPI 1063648640

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (48.0%), grants and food and beverage — rather than concentrated in one kind of arrangement. 5 manufacturers reported payments, led by Arthrex at 57.4% of the total. Reporting peaked in 2020 at $27,875 and has fallen 99.9% since, to $22 in 2024.

$43,090in general payments, 2019–2025

Across 43 payments — averaging $1002.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$25K
  • Smith+Nephew$16K
  • Gotham Surgical Solutions & Devices, Inc.$1K
  • Stryker$1K
  • Impactortho, Inc.$27

What the payments were for

  • Grants$20,00046%
  • Travel & lodging$9292%
  • Food & beverage$1,4603%
  • Education$20,70048%

General payments by program year

20
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Arthrex24$24,747
Smith+Nephew3$15,772
Gotham Surgical Solutions & Devices, Inc.2$1,329
Stryker12$1,215
Impactortho, Inc.2$27

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$43,090 in reported general payments places this provider in the 85th percentile of 83 orthopaedic surgery providers in Hawaii.

See all orthopaedic surgery providers in Hawaii

Medicare billing

Part B allowed, 2024
$583
Medicare patients
11
Services billed
13

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl42$402
Ibuprofen40$324
Cephalexin36$282
Ondansetron OdtOndansetron42$237

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Honolulu

See the full list for Hawaii

Where these figures come from

Is this you, or does something look wrong? →